Ajanta Pharma Aripiprazole Tablets 30mg: Mix-up with Voriconazole Risk
Ajanta Pharma recalls 30mg Aripiprazole tablets due to mix-up with Voriconazole tablets. This could lead to incorrect medication use. Check your NDC 27241-056-03 lot PA00805.
Lower-risk recall
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Contact the company
What happened, in plain English
Ajanta Pharma is recalling 30mg Aripiprazole tablets that were mistakenly labeled as Voriconazole. This mix-up could cause someone to take the wrong medication, which might lead to serious health issues. Read more at govinfonow.com/recall/31285-ajanta-pharma-aripiprazole-tablets-30mg-mix-up-with-voriconazole-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/31285-ajanta-pharma-aripiprazole-tablets-30mg-mix-up-with-voriconazole-risk · Updated August 10, 2026 · FDA enforcement record: FDA #D-0594-2026
Cite this page
“Ajanta Pharma Aripiprazole Tablets 30mg: Mix-up with Voriconazole Risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31285-ajanta-pharma-aripiprazole-tablets-30mg-mix-up-with-voriconazole-risk. Based on FDA recall #D-0594-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0594-2026%22&limit=1).
Why it’s dangerous
The tablets were labeled incorrectly as Aripiprazole when they are actually Voriconazole. Voriconazole is an antifungal medication, not a psychiatric drug. Taking the wrong medication could cause serious health problems.
Who’s affected
People who have the specific 30mg Aripiprazole tablets with NDC 27241-056-03 and lot number PA00805 are affected. Those taking prescription medication for mental health conditions are most at risk.
How to tell if you have this one
Check for the NDC code 27241-056-03 and lot number PA00805 on the bottle. The product was made in India and expires January 31, 2029.
- Brand
Ajanta Pharma- Category
Drug
What to do — step by step
Check Your Medication
Look for the NDC code 27241-056-03 and lot number PA00805 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 28 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Ajanta Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0594-2026 (May 27, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0594-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.